Skip to main content
MIRM logo
MIRM
(NASDAQ)
Mirum Pharmaceuticals, Inc.
$95.65-- (--)
Loading... - Market loading

Mirum Pharmaceuticals (MIRM) Stock Price & Financial Analysis

Mirum Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$95.95 - $99.91
52-Week High$112.00
52-Week Low$42.89
Open$96.23
Volume553.89K
Average Volume (3M)1.04M
Market Cap4.80B
Shares Outstanding50.20M
Price to Sales (P/S)9.84
Price to Book (P/B)16.30
EV/EBITDA369.21
Revenue (TTM)521.31M
Net Income (TTM)-23.36M
Free Cash Flow (TTM)54.87M
EPS (TTM)$-0.45
Profit Margin-4.48%
Operating Margin-4.25%
Return on Equity (ROE)-7.42%
Debt to Equity1.02
50-Day MA$94.69
200-Day MA$81.56
52-Week Change132.98%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Mirum Pharmaceuticals

What is the current stock price for MIRM?

As of the latest trading session, MIRM stock trades at $96.95. The 52-week range is $42.89–$112.00, with a day range of $95.95–$99.91.

What is the P/E ratio for MIRM?

The P/E ratio (Price-to-Earnings) for MIRM is shown in the Key Statistics section. This valuation metric helps compare Mirum Pharmaceuticals, Inc. to industry peers.

Does MIRM pay dividends?

Mirum Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MIRM?

Based on 9 analysts, the consensus for MIRM is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of MIRM?

Mirum Pharmaceuticals's market capitalization is $4.87B, classifying it as a mid-cap company..